Weight-loss pharmacology has a history — and a cautionary one
From 2,4-Dinitrophenol (banned 1938) to Fen-Phen (withdrawn 1997) to lorcaserin (withdrawn 2020), the market has repeatedly seen effective drugs pulled for safety. Each withdrawal changed how regulators evaluate obesity medications — and why today's approvals demand cardiovascular outcome data.
The practical takeaway
Use approved medications under medical supervision, report side effects, and treat "miracle" claims with the skepticism this history justifies. Get matched with a provider who follows the evidence — past and present.
